Medicines More Affordable
At the Kamol Med Farm enterprise in Namangan, new facilities for the production of medical items have been put into operation.
To date, dozens of types of alcoholic solutions are produced here, such as medical alcohol, camphor, menovazine, iodine, boric and salicylic acid. As of August 1, medical drugs have already been produced for more than 5.6 billion soums or in over 11.1 million packages.
In the new factory, built on the technology of the Chinese company Zhejiang Jiangnan Pharmaceutical Machinery Co., Ltd, opportunity is created for the production of 17.8 million packs of tablets a year, 1.6 million packages of medical capsules, and 4 million sachets.
At present, exemplary batches of drugs such as omeprazole, ciprofloxacin, acyclovir, cinepar, ambroxol, persen, Essentiale Forte N, koldrem have been manufactured and transferred for pharmacological registration. Starting from the fourth quarter of 2018, the production of camphor oil is planned, olive, almond and black cherry oil is projected to be extracted starting from 2019.
“The resolution of the President of our country “On Measures for Cardinal Improvement of the Pharmaceutical Sector Management System”, signed 7 November 2017, brought the development of the industry to a new level,” says the enterprise manager D.Kholmirzayev. “It envisages continual establishment of medicine production facilities in accordance with international standards, providing the population and healthcare institutions with affordable and high-quality medicines. In order to create optimal conditions for increasing the volume of production of pharmaceutical goods and increasing the industry’s competitiveness, raw materials and equipment supplied from abroad are exempt from customs duties. This is important for the development of our activities.
“Using these opportunities and benefits, starting from the fourth quarter of this year it is planned to establish the production of 4 types of tablets, 3 kinds of capsules and granules for drinking, and 4 kinds of biologically active additives. At the same time, based on the Program for the Development of Industrial Potential of the Namangan Region in 2016-2019, substances from local medicinal plants, injections, ointments and suppositories are projected to be produced.
“In addition, the enterprise is included in the Localization Program. In order to ensure its execution from abroad, equipment for the production of medical cotton wool, bleaching, cleaning, and gauze staining has been supplied and used. More than $ 140 thousand was spent on this work.”
According to D.Kholmirzayev, the volume of production in 2019 will increase 4-4.5 times as compared to 2018, and 32 additional jobs will be created. Currently, the company employs about 60 people.